Common Contracts
6 similar Warrant Agreement contracts by ENDRA Life Sciences Inc., Hancock Jaffe Laboratories, Inc., Petra Acquisition Inc.
REVELATION BIOSCIENCES, INC. COMMON STOCK WARRANT January 31, 2021 Void After January 31, 2027Warrant Agreement • September 20th, 2021 • Petra Acquisition Inc. • Blank checks • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, National Securities Corporation, or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Revelation Biosciences, Inc., a Delaware corporation (the “Company”), Sixty-One Thousand Six-Hundred (61,600) fully-paid and non-assessable shares of Common Stock of the Company. This Warrant is being issued pursuant to that certain Placement Agent Agreement by and between the National Securities Corporation and the Company, dated January 27, 2021 (the “Agreement”).
HANCOCK JAFFE LABORATORIES, INC. COMMON STOCK WARRANT February [___], 2020 Void After February [___], 2025Warrant Agreement • March 2nd, 2020 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [ ], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”), [ ][1] fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of February 25, 2020 (the “Agreement”).
ENDRA LIFE SCIENCES INC. COMMON STOCK WARRANTWarrant Agreement • December 26th, 2019 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [__________], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), [________]1 fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of December 19, 2019 (the “Agreement”).
ENDRA LIFE SCIENCES INC. COMMON STOCK WARRANTWarrant Agreement • December 11th, 2019 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [__________], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), [________]1 fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of December 5, 2019 (the “Agreement”).
ENDRA LIFE SCIENCES INC. COMMON STOCK WARRANTWarrant Agreement • July 29th, 2019 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, __________, or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), _________ fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of July 26, 2019 (the “Agreement”)
ENDRA LIFE SCIENCES INC. COMMON STOCK WARRANTWarrant Agreement • July 2nd, 2018 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [_________], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), [_________] fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of June 28, 2018 (the “Agreement”)
